We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

176 hedge funds and large institutions have $807M invested in Meridian Bioscience Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 65 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 50

22% more capital invested

Capital invested by funds: $659M → $807M (+$148M)

20% more call options, than puts

Call options by funds: $3.53M | Put options by funds: $2.93M

18% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 17

1% more funds holding

Funds holding: 175 → 176 (+1)

Holders
176
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
4.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
65
Reduced
50
Closed
17
Calls
$3.53M
Puts
$2.93M
Net Calls
+$600K
Net Calls Change
+$1.99M

Top Buyers

Rank Fund Capital Flow
1
BTW
Boston Trust Walden
Massachusetts
+$16.4M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$12.6M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.76M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.51M
5
BFA
BlackRock Fund Advisors
California
+$2.77M

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$17.3M
2
UBS AM
UBS AM
Illinois
-$3.73M
3
Millennium Management
Millennium Management
New York
-$3.54M
4
CPCM
Clifton Park Capital Management
Delaware
-$2.97M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICOM
26
Investment Counselors of Maryland
Maryland
$5.11M +$165K +8,600 +4%
JP Morgan Chase
27
JP Morgan Chase
New York
$4.92M +$76.4K +3,987 +2%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$4.76M +$3.76M +195,985 +544%
NFA
29
Nationwide Fund Advisors
Ohio
$4.34M -$304K -15,845 -7%
Ameriprise
30
Ameriprise
Minnesota
$4.18M +$17.8K +931 +0.5%
GF
31
Gabelli Funds
New York
$4.1M +$95.9K +5,000 +3%
WBC
32
Westpac Banking Corp
Australia
$4M – – –
PAM
33
Panagora Asset Management
Massachusetts
$3.71M +$1.94M +101,169 +127%
Invesco
34
Invesco
Georgia
$3.64M +$195K +10,196 +6%
Deutsche Bank
35
Deutsche Bank
Germany
$3.4M -$804K -41,955 -20%
BIM
36
BlackRock Investment Management
Delaware
$3.32M +$26.6K +1,385 +0.9%
CIS
37
Connors Investor Services
Pennsylvania
$3.11M -$1.25K -65 -0%
SLG
38
Stanley-Laman Group
Pennsylvania
$3.04M +$1.46M +76,042 +105%
New York State Teachers Retirement System (NYSTRS)
39
New York State Teachers Retirement System (NYSTRS)
New York
$3.02M – – –
GI
40
GAMCO Investors
Connecticut
$2.87M – – –
TCIM
41
TIAA CREF Investment Management
New York
$2.85M -$61.1K -3,189 -2%
TA
42
Teton Advisors
New York
$2.83M – – –
MC
43
Menta Capital
California
$2.72M +$159K +8,304 +7%
Goldman Sachs
44
Goldman Sachs
New York
$2.65M -$373K -19,447 -13%
PCM
45
Piermont Capital Management
Missouri
$2.5M +$2.34M +121,819 New
Arrowstreet Capital
46
Arrowstreet Capital
Massachusetts
$2.46M +$330K +17,209 +17%
ZAM
47
Zevin Asset Management
Massachusetts
$2.44M +$349K +18,180 +18%
EAM
48
Edge Asset Management
Washington
$2.44M -$691K -36,024 -23%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$2.42M +$94.4K +4,925 +4%
RC
50
Randolph Company
Ohio
$2.2M -$10.5K -550 -0.5%
1
2
3 4 5

VIVO Hedge Fund Activity: Q4 2015 in Review

176 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2015, worth a combined $807M — up 22% from $659M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VIVO positions and 17 closed out — a net gain of 3 holders — while 65 added to existing stakes and 50 trimmed.

The largest buyer was Boston Trust Walden, opening a new position worth an estimated $16.4M. The largest seller was Neuberger Berman Group, cutting an estimated $17.3M.

  • 176 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2015, up from 175 in Q3 2015.
  • Funds reported $807M of Meridian Bioscience Inc stock for Q4 2015, up 22% quarter-over-quarter.
  • 20 funds opened new Meridian Bioscience Inc positions in Q4 2015 and 17 closed out, a net change of +3 holders.
  • The largest Meridian Bioscience Inc buyer in Q4 2015 was Boston Trust Walden, an estimated $16.4M added.
  • The largest Meridian Bioscience Inc seller in Q4 2015 was Neuberger Berman Group, an estimated $17.3M sold.

Based on aggregated 13F filings for Q4 2015.